Drug General Information (ID: DDI4AS7H9W)
  Drug Name Valaciclovir Drug Info Probenecid Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antiviral Agents Uricosuric Agents
  Structure

 Mechanism of Valaciclovir-Probenecid Interaction (Severity Level: Minor)
     Competitive inhibition of renal tubular secretion Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Valaciclovir Probenecid
      Mechanism Valaciclovir Competitive inhibition of renal tubular secretion of acyclovir/valacyclovir/famciclovir
      Key Mechanism Factor 1
Factor Name Renal tubular secretion
Factor Description Renal tubular secretion allows selective transfer of substances from the blood around the capillaries into the renal tubules via filtrate. Drug excretion may be reduced when two drugs compete for renal tubular secretion.
      Mechanism Description
  • Decreased elimination of Valaciclovir caused by Probenecid mediated competitive inhibition of renal tubular secretion

References
1 Laskin OL, de Miranda P, King DH, et al "Effects of probenecid on the pharmacokinetics and elimination of acyclovir in humans." Antimicrob Agents Chemother 21 (1982): 804-7. [PMID: 7103460]
2 Product Information. Valtrex (valacyclovir). Glaxo Wellcome, Research Triangle Park, NC.
3 Soul-Lawton JH, Weatherley BC, Posner J, Layton G, Peck RW. Lack of interaction between valaciclovir, the L-valyl ester of aciclovir, and digoxin.?Br J Clin Pharmacol. 1998;45(1):87-89. [PMID: 9489600]